Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine vs Placebo for Atracurium Reversal During Extubation
NCT07097441Phase 2Completed
- Sponsor
- Ziauddin University
- Start
- Mar 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neostigmine in Residual paralysis (PORP), sponsored by Ziauddin University. Started Mar 2025; status: completed.
02
Drugs
neostigmine
03
Conditions
Residual paralysis (PORP)
Beyond the preview
Go deeper on NCT07097441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07097441.